An interventional study of Mid-Infrared Spectroscopy with ATR in Gynecological Malignancies, sponsored by Hillel Yaffe Medical Center. Status unknown at 1 site in Israel. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-03-24.
Sponsored by Hillel Yaffe Medical Center · Not applicable, Interventional, and Diagnostic
The purpose of this study is to examine the efficacy of mid-infrared spectroscopy together with Attenuated Total Reflection (ATR), for the detection of gynecological malignancies in real time during surgery.
Hillel Yaffe Medical Center is the lead sponsor of 305 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Frozen sections taken from women operated on for possible gynecologic malignancies.
Device: Mid-Infrared Spectroscopy with ATR
Gynecological Malignancies Identified in Real Time
Results of Spectroscopy will be compared to frozen section/histopathology findings
Time frame: One hour
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.